当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Nature Protocols杂志
Nature Protocols
基本信息
期刊名称 Nature Protocols
NAT PROTOC
期刊ISSN 1754-2189
期刊官方网站 https://www.nature.com/nprot
是否OA No
出版商 Nature Publishing Group
出版周期 Quarterly
文章处理费 登录后查看
始发年份 2006
年文章数 136
影响因子 13.1(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
生物1区 BIOCHEMICAL RESEARCH METHODS 生化研究方法1区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 29.1 7.419 3.387
Biochemistry, Genetics and Molecular Biology
General Biochemistry, Genetics and Molecular Biology
5/221 97%
补充信息
自引率 0.8%
H-index 206
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1754-2189%5BISSN%5D
投稿指南
期刊投稿网址 https://mts-np.nature.com/
收稿范围
Nature Protocols publishes secondary research articles - predominantly Protocols (including Protocol Updates and Protocol Extensions), but also techniques-related Reviews, Perspectives, Correspondences, Matters Arising, Commentaries, and Consensus Statements - all of which are based on published primary research papers. We cover new techniques and technologies, as well as established methods, used in all fields of the biological, chemical and clinical sciences. Articles are commissioned by the editors. Authors are welcome to submit suggestions for articles as Presubmission Enquiries, which may then be formally commissioned by the editors.

Each Protocol contains a full list of reagents and equipment, timing information, and step-by-step procedures (instructions for performing the experiment), as well as information on designing and adapting the technique, its advantages and limitations compared to alternatives, troubleshooting, analysing data, and interpreting results. We also encourage authors to submit videos for steps that are technically challenging.

All of our Protocols have been proven to work already (used to generate data in published papers), with further validation provided by peer review of the Protocols themselves. As a supporting primary research paper is a requirement for publication, novelty is not a prerequisite. However, it is important that our Protocols add value to the published literature and expand significantly upon the information available in the supporting papers (for example, with additional detail relating to experimental design, troubleshooting, data analysis, etc.). 

As we are not a primary research journal, our articles do not include new (previously unpublished) research findings and should only contain minimal new supporting data relating specifically to development of the Protocol (e.g. validation, benchmarking, and troubleshooting data). To ensure we provide the most up-to-date version of a Protocol, the procedure may sometimes deviate slightly from the version used in the supporting paper, but all minor modifications must be clearly discussed. Any major improvements, adaptations, or extensions of a Protocol should be supported by the publication of an additional supporting primary research paper. 

In addition to Protocols, we also publish other types of techniques-related articles.
收录体裁
Protocol, Protocol Update, Protocol Extension, Correspondence, Matters Arising, Perspective, Commentary, Review, Analysis
投稿指南 https://www.nature.com/nprot/for-authors
投稿模板
参考文献格式 https://www.nature.com/nprot/for-authors/preparing-your-submission
编辑信息

Chief Editor: Melanie Clyne, PhD ORCID

Mel joined Nature Protocols in June 2014 and leads the journal's editorial team. Mel completed her PhD at the Genome Damage and Stability Centre, University of Sussex, where she studied cisplatin resistance in mismatch-repair-defective cells. She continued this research with a brief stint as a postdoctoral scientist before making the transition from laboratory-based research to medical publishing in 2009. She worked—first as an Editorial Assistant, and then as a Clinical Writer—for Map of Medicine, drafting peer-reviewed treatment guidelines for the NHS, and helping local healthcare communities to evaluate the impact of service redesign. Mel joined Nature Publishing Group in September 2011 as an Editor for Nature Reviews Urology, before taking up her current position at Nature Protocols. She is based in the London office.

m.clyne@nature.com

Managing Editor: Katharine Barnes, PhD ORCID

Katharine joined Nature Protocols in January 2006 as Chief Editor and led the editorial team of Nature Protocols until November 2009, when she stepped down from the full-time Chief Editor role to become Managing Editor, working part-time. Before joining Nature Protocols Katharine was Editor of Trends in Pharmacological Sciences. A graduate of the University of Durham, UK, she completed her PhD in cancer pharmacology at the Institute of Cancer Research, London. Her postdoctoral research, based in the University of Pittsburgh's Department of Pharmacology, was focused on the phosphatase CDC25 and its potential as a target for anti-cancer drug development. She is based in the London office.

k.barnes@nature.com

Senior Editor: Bronwen Dekker, PhD ORCID

Bronwen Dekker did a masters in Natural Product Chemistry (under Dulcie Mulholland, University of Natal) and worked in the toxicology section of a forensic science laboratory before doing a PhD under Jamal Zweit and Alastair Watson in the Radiochemical Targeting and Imaging group at the Paterson Institute for Cancer Research. After a radiochemistry post-doc in Steve Mather's laboratory at St Bartholomew's hospital, she joined Nature Protocols in February 2006. She is based in the Berlin office.

b.dekker@nature.com

Senior Editor: Hannah Clark, PhD ORCID

Hannah obtained her MA in Biological Sciences from the University of Oxford (St. Hilda's College) before undertaking a Ph.D. in Equine Parasitology, investigating the molecular mechanisms of benzimidazole resistance in equine small strongyles. This was completed under the supervision of Dr. Jane Hodgkinson at the Liverpool School of Tropical Medicine, University of Liverpool. Hannah joined Nature Protocols as an Assistant Editor in July 2006. She is based in the London office.

hannah.clark@nature.com

Senior Editor: Mathijs Vleugel, PhD ORCID

Mathijs received his PhD training at Utrecht University (The Netherlands), where he investigated the molecular evolution of cell cycle regulation under the supervision of Prof. Geert Kops. After obtaining his PhD in 2014, Mathijs did his post-doctoral research in the group of Prof. Marileen Dogterom at the University of Technology in Delft. During this period, he worked on the in vitro reconstitution of mitotic spindles using microfluidic technologies. Mathijs joined Nature Protocols as an Associate Editor in January 2017. He is based in the Berlin office.

mathijs.vleugel@nature.com

Associate Editor: Ivanka Kamenova, PhD ORCID

Ivanka obtained her PhD in Molecular and Cellular Biology in 2013 from the University of Washington, Seattle where her research focused on characterizing TATA-less promoters in Saccharomyces cerevisiae under the supervision of Steve Hahn at the Fred Hutch. After that she moved to the IGBMC in Strasbourg, France to work in Laszlo Tora’s group, studying how protein domain organization guides co-translational assembly of multi-subunit complexes in mammalian cells using genomics and single molecule imaging methods. She joined Nature Protocols in April 2018 as an Associate Editor. She is based in the London office.

ivanka.kamenova@nature.com

Editorial Assistant: Beata Ghavimi

Beata has a BSc in Economics from the London School of Economics and Political Science and specialised in international trade and development economics. She has previously worked as a researcher in the editorial department of The Banker magazine at The Financial Times Group. Beata joined Nature Protocols in March 2016. She is based in the London office.

protocols@nature.com

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug